¹Internal comparative study between Withings Body Scan measurements and DEXA scan results. 99% correlation observed on fat mass results. Individual results may vary. BodyScan 2 is not a medical device for diagnostic purposes.
²Withings Hypertension Notification is a software-only medical-grade device that analyses demographic, anthropometric, and physiological parameter data opportunistically collected by Withings devices to identify patterns that are suggestive of hypertension and provides a notification to the user.
This feature detects possible signs of hypertension. It is not a diagnosis and does not measure blood pressure. If notified, confirm the results with a clinically validated blood pressure monitor and consult a healthcare professional. Regular home BP monitoring and discussing results with your doctor remain the best way to support your long-term health.
³AFib detection is available via Withings ECG Monitor 2
Withings ECG Monitor 2 is a software medical device that analyses and filters ECG signals from compatible devices to detect atrial fibrillation (AFib) and classify heart rate.
Intended for healthcare professionals and/or lay users, it provides information to support rhythm classification and help distinguish AFib from sinus rhythm. Results are for informational purposes only and should not replace professional medical advice, diagnosis, or treatment.
Not recommended for users with other known arrhythmias. For adults only.
⁴Available via Withings Hypertension Notification
⁵ Source:
The Pricer
These medical devices are regulated health products and, as such, bear the medical CE certification (14/04/2026).
Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or understood through the use of this device.
*Feature availability subject to software update. Some features require a Withings+ subscription.
BodyScan 2 is fully available for purchase in the United Kingdom and Switzerland. However, the Hypertension Notifications feature is not yet authorized for use in these countries and will not be active at launch. It is expected to become available through a future software update, subject to local regulatory approval. All other features are available as described.